Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Extends Biomarker Pact with Universities

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it has extended a biomarker research effort with George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM), Johns Hopkins University, and Toronto's University Health Network (UHN).

The firm's Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center has been working with the universities over the past two years to accelerate the verification and validation of protein biomarkers for cancer and other diseases. The agreement announced today extends that collaboration, though Thermo Fisher did not disclose the length of the extension.

The BRIMS Center is developing targeted quantitative mass spectrometry workflows that enable rapid assay development and cross validation of biomarker assays. It said that each of the collaborators is using these biomarkers and assays to perform research on Thermo's TSQ Quantum Ultra triple quadrupole mass spectrometer platforms.

"By delivering reproducible, quantitative verification and validation of protein biomarkers in a clinical research setting, the researchers are now that much closer to their goal of developing tests for cancer," Iain Mylchreest, VP and general manager of life science mass spectrometry for Thermo Fisher Scientific, said in a statement.

Among the collaborators in the effort are Lance Liotta and Emanuel Petricoin, co-directors of George Mason University's Center for Applied Proteomics and Molecular Medicine.

Members of the collaboration presented their results of a study on inter-lab reproducibility of the technology at a recent meeting of the US Human Proteome Organization, said Thermo. It said that the study showed that an optimized biomarker assay can be implemented relatively quickly across several laboratories without need for additional optimization.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.